Try our Advanced Search for more refined results
Life Sciences - March, 2025
281 articles
- Texas Judge Deems Lab-Test Rule Outside FDA Authority
- Former Stimlabs Exec Must Face Trade Secrets Claims
- Ex-Blood Bank Atty Goes Back To Ballard Spahr In Phoenix
- Nasdaq's Tighter IPO Rules Raise Bar For Small Companies
- Buyer Class Of Surgical Robots Is Certified In Antitrust Fight
- J&J Talc Spinoff's Ch. 11 Case Gets Tossed, Erasing $9B Deal
- Despite 'Admirable' Effort, Vertex Kickback Challenge Fails
- Pierson Ferdinand Adds Taylor English Health Pro In Atlanta
- Firms Must Embrace Alternative Billing Models Or Fall Behind
- Key Issues To Watch As USPTO Changes Abound
- Cleary Gains 5-Atty Latham Team Known For Big IP Wins
- Colo. Beats Amgen's Drug Price Cap Challenge, For Now
- Janssen Owes Additional $1.5B In HIV Prescription Trial
- PE Firm Hits Back Against Medical Device Coating Challenge
- Purdue Lawsuit Injunction Extended Ahead Of Plan Hearings
- Pot Co.'s Challenge To DEA Admin Procedures Dismissed
- 13 Drugmakers Seek Dismissal Of Aetna's Price-Fixing Claims
- Labcorp Denied Early Win In 401(k) Fee Suit
- Azzur Judge OKs At Least $1.3M In Potential Exec Bonuses
- Trending At The PTAB: A Pivot On Discretionary Denials
- 3rd Circ. Preview: April Arguments Feature Class Action Rows
- Fed. Circ. Upholds Janssen's Patent Case Win Over Mylan
- CureVac RNA Vax Patent Survives BioNTech's EU Challenge
- How Attorneys Can Master The Art Of On-Camera Presence
- Taxation With Representation: Norton Rose, Latham, Ashurst
- Jury Clears Lab Owners In $40M COVID Test Fraud Case
- Diopsys Inks $14M Deal Resolving Vision Testing FCA Claims
- New Procedures Expected To Result In More PTAB Denials
- Vaping Interests Take Challenge To FDA Rule To 5th Circ.
- Fertility Co. Wants To Pull Device Maker Into Negligence Suit
- Texas Judge 'Disturbed' By Filings In Weight Loss Drug Case
- Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP
- Fitch Even Sues Ex-IP Client In Effort To End Malpractice Case
- Oura Gets Samsung's Preemptive IP Strike Tossed, For Now
- Ga. Therapy Clinic Accused Of Refusing OT Payments
- Patent Drafting Pointers From Fed. Circ. COVID Test Ruling
- Congress Must Reform The PTAB To Protect Small Innovators
- Eli Lilly Says Michigan AG's Insulin Pricing Probe Is Baseless
- Walgreens To Pay $2.8M For Alleged Medicaid Overcharges
- Mich. Judge Deflects Criticism Of Atty Fees In $53M Flint Deal
- Fox Rothschild Brings On McCarter & English IP Ace In NJ
- Baseball Fantasy Camp Makes Me A Better Lawyer
- Texas Law Firm Must Face 2nd Firm's Paxil Fees Suit
- Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine
- 1st Circ. Denies Gov't Bid To Enforce Funding Freeze
- HHS To Cut 10,000 Jobs As RFK Jr. Reorganizes Agency
- Sotomayor Urges Caution On Nondelegation Doctrine Revamp
- 7 Firms Compete To Lead Novo Nordisk Securities Suit
- 23andMe Says Ch. 11 Privacy Ombudsman Not Required
- Full Fed. Circ. Won't Look At Injunction On MSN's Generic Drug
- Drugmaker Execs Hid Approval Process Roadblocks, Suit Says
- Women Make Up 13% Of Attys In Front Of The PTAB
- Walgreens, Kroger Claim Takeda Cut Illegal TWi Generics Deal
- Del. Justices Back Axing Suit Over $3B AstraZeneca Viela Sale
- AGs Seek 1st OK For $39M Apotex Deal In Price-Fixing Case
- False COVID Cure Claims No Longer Feds' 'Current Priority'
- Adapting To Private Practice: From Fed. Prosecutor To BigLaw
- Fla. Appeals Court Upholds Fees For Medical Pot Businesses
- Need For Individual Analyses Sinks Class Bid In Vax Bias Suit
- Ex-Masimo CEO Slams Bid To DQ His Hueston Hennigan Attys
- Medical Image Co. Gets Fed. Circ. To Back Ax Of Rival's IP
- Drug Co. Wants Fed. Circ. To Undo Pfizer COVID Patent Win
- What To Expect For Stem Cell Regulation Under Trump Admin
- Pension Seeks To Opt Class Out Of Cutera Ch. 11 Releases
- McCarter & English's $3.77M Fee Win Headed For Appeal
- Merck Betting Up To $2B On China-Developed Cardio Drug
- Meitar-Led Navina Wraps $55M Series C Funding Round
- 4th Circ. Won't Rehear Drug Price-Fixing Class Action
- Trump Picks Acting CDC Head After Weldon Nomination Fails
- Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out
- Kenvue, J&J Must Face Investor Suit Over FDA Concerns
- Justices Urged To Weigh In On Skinny Label Dispute
- Period App Users Get $3.5M In Privacy Deal With Analytics Co.
- United Healthcare Escapes Some Of Diagnostic Co.'s Claims
- Investors Blame Electrotherapy Co.'s Practices For Stock Drop
- Seattle Biotech Duped Investors On Drug Progress, Suit Says
- Apple, Sony, Others Facing ITC Probes Over Imports
- Fla. Judge OKs $19.3M In Spinal Products Noncompete Suit
- Norton Rose, Latham Steer Alcon's $430M Lensar Buy
- Firms Still Have Lateral Market Advantage, But Risks Persist
- Novartis Urges Court To Make FDA Block Entresto Generic
- Fed. Circ. Revives Blood Pump Patent Suit Against J&J Unit
- 10 Practical Takeaways From FDA's Biopharma AI Guidance
- Bausch & Lomb Says Amcor Must Pay For Botched Bottles
- Judge Accused Of Bias Expresses Regret Over MDL Remarks
- We Must Allow Judges To Use Their Independent Judgment
- New Mexico Lawmakers Approve Medical Psilocybin Bill
- Exactech Strikes $10M Deal With TPG In Ch. 11
- Taxation With Representation: Cravath, Paul Weiss, Cooley
- AstraZeneca To Invest $2.5B In China Research Hub
- Fed. Circ. Backs Actavis' $12M Patent Suit Cost Deduction
- Texas Says Planned Parenthood Can't Get Atty Immunity
- Class In Bayer 'One A Day' Gummies Lawsuit Gets Judge's OK
- 8th Circ. Won't Pause FTC's Insulin Pricing Case
- MiMedx Challenges FDA Classification Of Wound Care Powder
- 6th Circ. Judge Skeptical Of Mich. Newborn Screening Ruling
- Oracle Eyes Stake In TikTok's US Entity, And More Rumors
- Medical Malpractice Insurers Ink $1.3B Merger Deal
- Performing Stand-Up Comedy Makes Me A Better Lawyer
- Ohio Judge Blasts Fla. Atty In Opioid MDL For False Statements
- Sotera Beats Shareholder Suit Over Sterigenics Emissions
- Unpacking The Illicit E-Cigarette Crackdown By State AGs
- Lawmakers Shouldn't Overlook Rare Disease Therapies' Value
- Ohio Opioid Judge Says Texas Court Should Hear Appeal Bid
- Adapting To Private Practice: From SEC To BigLaw
- Pillsbury Adds Commercial Deal Pro From A&O Shearman
- Law360 Announces The Members Of Its 2025 Editorial Boards
- Advanced Instruments Buys Nova Biomedical In $2.2B Deal
- Purdue Pharma Files New $7.4B Ch. 11 Plan Settlement
- Emisphere, Novo Nordisk Sale Suit On Track For Settlement
- ITC To Review Whether Tourniquet Importers Are Ignoring Ban
- Full 9th Circ. Mulls Reviving Workers' LA Schools Vax Fight
- Drugmaker's $10.5M Deal In Investor FDA Approval Suit OK'd
- HHS Seeks Early Win Over Lilly, Novartis, BMS In Rebate Row
- Lab Co-Founder Takes Stand For Gov't In $40M Testing Case
- J&J Denies 'Evil Motive' In Face Of $30M Talc Damages
- Ga. Hospital Failed To Protect Data Of 120K, Patient Says
- Bausch Eye Vitamin Case Should Go To Jury, Judge Says
- China High Court Ruling Could Encourage Antitrust Litigation
- MilliporeSigma Says Rival Raided Workers Under Non-Solicits
- AI Healthcare Co. Accuses Test-Maker Of Infringing Patents
- States Oppose Term In Sandoz Price-Fixing Deal With Fla.
- Indirect Effexor Buyers Seek Approval Of $2.3M Antitrust Deal
- Greenberg Traurig Boosts Litigation Team With 4 Denver Attys
- Making The Case For Rest In The Legal Profession
- Novartis Nabs Partial Ban Against MSN's Heart Drug Generic
- Ex-Opioid Co. CEO Wants Out Of Law Firm's Billing Suit
- New Bills Target 'Patent Thickets' And 'Product Hopping'
- Doctor Pays $700K To Settle Feds' Medicare Fraud Suit
- Jazz Inks Insurer Class Deal As Xyrem Antitrust Trial Nears
- Court Won't Toss Biotech Co.'s Antitrust Counterclaim
- Full 7th Circ. Won't Revive Suit Over Late Medicaid Payments
- How Amended Rule 702 Affects Testimony In Patent Litigation
- What Trump's Order Means For The Legal Status Of IVF
- NC AG Fights TikTok's Early Exit From Addiction Suit
- Yale Says Researcher's Omissions Doom $28M Incubator Suit
- Mitigating Tariff Risks For Healthcare In US And Canada
- Austrian Biotech BIA Hits Ch. 15, Says Exec Stole $22M
- Seeger Weiss Atty Tapped To Lead Depo-Provera Plaintiffs
- 4 Firms Guide Up To $1.14B Sale Of PE-Backed Biotech
- 4 Ways Women Attorneys Can Build A Legal Legacy
- PTAB Explains Why It Invalidated Moderna's COVID Vax Patents
- Market Turbulence Threatens To Stall IPO Recovery
- Ex-NJ Health Official Settles Suit Over COVID Whistleblowing
- Fed. Circ. Affirms No Block On Amgen's Eye Med Biosimilar
- Antigua Clinic Accused Of Lying About 'Miracle' Cancer Cure
- Biotech Wins Dismissal Of Investor Fraud Claims
- 1st Circ. Asked To Look At Takeda Invoice Fraud Conviction
- Green Groups Sue Fed. Agencies Over Frozen Funding
- FTC Urges 8th Circ. Not To Pause Insulin Pricing Case
- Dr. Oz Pledges 'Upcoding' Crackdown If Confirmed At CMS
- A Judge's Pointers For Adding Spice To Dry Legal Writing
- Colo. Jury Rejects Claims Sterilization Co. Caused Cancer
- Taxation With Representation: Davis Polk, Paul Weiss
- Preparing For Disruptions To Life Sciences Supply Chains
- SEC's Expansion Of Confidential Filings Likely To Spur Deals
- Fed. Circ. Sides With Merck In Reissued Patent Debate
- Merck Asks Justices To Block Fosamax Failure-To-Warn Suits
- Calif. AG Appealing State Limits On Pay-For-Delay Ban
- Fed. Circ. Dings Antibody Patent App For Lacking Description
- PBMs Tell FTC 5-Month Delay Too Long For In-House Insulin Trial
- HHS Calls Back Terminated Attys Clearing Medicare Appeals
- 9th Circ. Ends Idaho Abortion Law Row After Mutual Dismissal
- Mastering The Fundamentals Of Life Sciences Due Diligence
- Beware Risks Of Arguing Multiple Constructions In IP Cases
- 6 Firms Steer $6.7B Mallinckrodt, Endo Pharma Merger
- Full 4th Circ. Urged To Rethink Drug Price-Fixing Class Action
- J&J Unit Drops Noncompete Suit Against Ex-Marketing Exec
- Days Into New Role, FDA's Top Lawyer Is Out
- Lacking Votes, White House Pulls Weldon Nomination At CDC
- Cancer Cause Or Red Herring? Jury Weighs Plant Bellwether
- Del. Justices Told Conflicts Tainted AstraZeneca Co.'s $3B Sale
- Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row
- Law360 Cheat Sheet: Novartis' Fight Over Generic Entresto
- SEC Says Ex-Allarity Execs Concealed Doomed FDA Approval
- Caribou Biosciences Brass Face Investor's Clinical Trials Suit
- COVID Test Device Maker Settles Fed. Circ. Feuds With Rival
- Publix Policies Don't Cover Opioid Claims, Court Says
- NC Organ Procurer Sues CMS Over Hospital Waiver
- What's At Stake In High Court Transgender Care Suit
- Cannabis Tech Co. Seeks Over $1M Interest On $4.2M Verdict
- HHS To Eliminate 6 Regional Offices For Legal Staff
- Harvard Docs Say Gov't Censored Articles With Gender Terms
- Mallinckrodt Investors Ask NJ Court To Approve $46M Deal
- McCarter & English Wins $3.77M From Ex-Client In Billing Spat
- 6th Circ. Ruling Paves Path Out Of Loper Bright 'Twilight Zone'
- Medical Device Co. Seeks Fed. Circ. Redo Over Patent Trial
- Kenvue Unit Can't Nix BIPA Suit Over Neutrogena Skin360 App
- 'Paucity' Of Proof Thwarts NC State Law Claims In Gardasil MDL
- More ITC Patent Cases Expected After Fed. Circ. 'Sea Change'
- Pharmacies To Appeal In Bid To Keep Making Weight Loss Drug
- J&J Tells 3rd Circ. No Price Impact In Talc Concealment Suit
- Brazilian 'Drug King' Ran Black Market Pharmacy, Feds Say
- Zydus Cuts Deal With States, Tribes In Opioid Nuisance Suit
- Eli Lilly Suit Over Compounded Drugs Survives Dismissal
- A Reminder On Avoiding Improper Venues In Patent Cases
- Alaska's RICO Claims Advance Against PBM In Opioid Suit
- Post Hit With False Ad Suit Over Rachael Ray Brand Pet Food
- Endo Sells International Pharma Biz To Knight For Up To $99M
- Publix's Suit Over Ga. County's Private Attys 'Beyond Reason'
- Trump Admin Drops Suit Over COVID Nasal Spray Ads Claims
- Sullivan & Cromwell Hires Ex-FTC Deputy Director In Palo Alto
- Ex-J&J Atty Says She Was Fired For Making Ethics Complaint
- White House Names Ex-Goldman Sachs Atty To Lead USPTO
- Illinois Judge Floats Sanctions In Akorn Mootness Fee Fight
- Amgen, Fresenius Settle Osteoporosis Drug Patent Dispute
- Masimo Founder Urges Toss Of 'Empty Voting' Suit
- Calif. Pharma Exec Pleads Guilty To Insider Trading
- DOJ Wants In On Invisalign Monopoly Arguments At 9th Circ.
- NIH Cuts To Indirect Costs May Stifle IP Generation
- Recent Cases Clarify FCA Kickback Pleading Standards
- Antitrust Analysis In Iowa Pathologist Case Misses The Mark
- GAO Says NIH Treated Bidders Disparately On $20M IT Deal
- CBD Co. Launches More Patent Suits Over Topical Cream
- Fed. Circ. Won't Pause Teva Patent Delisting For Appeal
- Ex-Magellan CEO Pleads Guilty Over Faulty Lead Tests
- FDA Can Take Eli Lilly Weight Loss Drug Off Shortage List
- AGs Say Anti-Trans Admin Puts $367M Hospital Grants At Risk
- Hints Of A New High Court Majority Emerge In Trump Cases
- Ohio, PBMs Say High Court Ruling Didn't End Pricing Appeal
- New Bellwethers Score Cert. In Generic Drug Price-Fixing MDL
- Apple Prevails In Watch Tech Patent Fight At Fed. Circ.
- Ex-Novo Nordisk Worker Can't Reopen Harassment Suit
- Tariffs, Diversity And DOGE Dominate Trump 2.0 'Risk Factors'
- State FCAs Should Cover Local Fund Misuse, State Tax Fraud
- Husband Of Ex-Takeda VP Gets 2½ Years For Invoice Scam
- Taxation With Representation: Kirkland, Wachtell, Skadden
- Don't Give Teva 'Eighth Bite' At $235M Patent Trial, GSK Says
- Pfizer Failed To Warn Of Depo-Provera's Tumor Risk, Suit Says
- Wheeling & Appealing: The Latest Must-Know Appellate Action
- FTC Challenges PE Firm's Medical Device Coatings Deal
- Walgreens Boots Inks $24B Go-Private Deal With Sycamore
- No Cancer Therapy Patent For AbbVie, Says Federal Circuit
- Attys Seek $30M Fees In Walgreens Rx Overcharge Deal
- 7 Tips For Associates To Thrive In Hybrid Work Environments
- FDA Nominee Hedges On Job Cuts, Abortion Drug In Hearing
- Kirkland-Led Medical Device Firm Prices Upsized $202M IPO
- Trump Administration Ordered To Release Funds To States
- Playing Beach Volleyball Makes Me A Better Lawyer
- Celltrion Can't Undo Eye Med Biosimilar Injunction On Appeal
- Teva Wants Pause Of Patent Delisting For High Court Appeal
- Pfizer Beats Claims Of Copay Aid Scheme For Good
- Nationwide Block Of Trump Trans Healthcare Orders Extended
- Biotech Co. Maravai Hit With Investor's Internal Controls Suit
- Senators Press Trump's NIH Nominee On Grant Cuts, Vaccines
- Pfizer, BioNTech Get PTAB To Invalidate Moderna Vaccine IP
- Trump's NIH Cost-Cutting Measure Blocked By Judge
- 3 Firms Build Jazz Pharmaceuticals' $935M Chimerix Buy
- Skin Care Tech Co. Files Ch. 11 With $400M Prepackaged Plan
- Meijer Says 1st Circ. Must Resolve Takeda Arbitration Order
- Gov't Says 2 Lab Owners Billed $40M In COVID Test Scheme
- Apple Seeks Ban Against Masimo's Original Smartwatch
- Fed. Circ. Affirms PTAB Decision Backing Stem Cell Patent
- Moderna Faces MRNA Vax Patent Suits In Canada And Beyond
- Alcon, Lens.com Settle 7-Year Trademark Fight In NY
- PBMs Ask 8th Circ. To Pause FTC's Insulin Pricing Case
- After 'Historic Low' In 2023, Number Of ITC Cases Soar In 2024
- What To Expect From 'Make America Healthy Again' Actions
- In Rare Move, Texas Judge Shuns Out-Of-State BigLaw Attys
- Freezer Co. Drops Supplier Suit Over $15M Embryo Loss
- How Law Firms Can Counteract The Loneliness Epidemic
- Colo. Biotech, Founders Owe SEC $14.3M Over Fraud Claims
- What's At Stake In High Court's Class Member Standing Case
- IRS Asks To Toss Abbott Labs' FOIA Action For Tax Records
- Lead Testing Operations Chief To Admit Misbranding Charge
- Feds Seek 40 Mos. For Husband Of Ex-Takeda Exec
- Ultragenyx Loses Bid To Toss Suit Over Henrietta Lacks' Cells
- Full Fed. Circ. Won't Take On Teva's Orange Book Appeal
- Sandoz Settles Florida's Generic Drug Price-Fixing Claims
- Teva Should Face Key Copaxone Antitrust Claims, Court Told
- Sanofi Grilled By Judge Over $1.2M In Amgen Patent Saga
- Calif. Farm Sues Tenn. Sheriff Over $3.9M In Destroyed Hemp
- Boston Scientific Buying $600M Ultrasound System Developer
- 5 Mass. Rulings You May Have Missed In February
- How Citizen Petitions Have Affected Drug Competition
- Convicted Drexel Professor Gets 2 Years For Tax Evasion
- Vape Co.'s Challenge Of FDA Penalty Rejected
- 5 Keys To Building Stronger Attorney-Client Relationships
- Jones Day Hires Pair Of Weil IP Litigators In California
- 3rd Circ. Preview: Litigation Funder, J&J Seek Relief In March
- Life Science Consulting Firm Hits Ch. 11 With Sale Plans